CETTO, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 5.105
EU - Europa 4.462
AS - Asia 1.198
SA - Sud America 12
AF - Africa 7
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.795
Nazione #
US - Stati Uniti d'America 5.093
GB - Regno Unito 1.561
CN - Cina 1.089
SE - Svezia 611
IT - Italia 505
IE - Irlanda 447
FR - Francia 439
FI - Finlandia 372
DE - Germania 284
UA - Ucraina 101
RU - Federazione Russa 56
BE - Belgio 36
IR - Iran 23
TR - Turchia 20
IL - Israele 17
IN - India 11
CA - Canada 9
NL - Olanda 9
JP - Giappone 8
CH - Svizzera 7
KR - Corea 7
BR - Brasile 6
AU - Australia 5
CZ - Repubblica Ceca 5
LV - Lettonia 5
RO - Romania 5
VN - Vietnam 5
EU - Europa 4
AL - Albania 3
AT - Austria 3
CL - Cile 3
EG - Egitto 3
HK - Hong Kong 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AR - Argentina 2
BD - Bangladesh 2
DK - Danimarca 2
ID - Indonesia 2
MX - Messico 2
PL - Polonia 2
PT - Portogallo 2
SG - Singapore 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
GR - Grecia 1
JM - Giamaica 1
KG - Kirghizistan 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
TH - Thailandia 1
Totale 10.795
Città #
Jacksonville 1.426
Southend 1.366
Chandler 811
Dublin 446
Woodbridge 446
Ann Arbor 297
Houston 294
Ashburn 230
Lawrence 164
Princeton 164
Wilmington 154
Nanjing 118
Jinan 112
Beijing 111
New York 108
Shenyang 108
Hebei 90
Milan 70
Tianjin 61
Ningbo 52
Zhengzhou 52
Boardman 44
Haikou 44
Nanchang 44
Helsinki 42
Sindelfingen 41
Hangzhou 40
Changsha 39
Brussels 35
Taizhou 35
Verona 33
Jiaxing 31
Lancaster 27
Norwalk 25
Falls Church 23
Fairfield 22
Seattle 21
Taiyuan 21
Fuzhou 19
Rome 19
Guangzhou 17
Philadelphia 17
Lanzhou 13
Parma 12
Chicago 10
Dearborn 9
Auburn Hills 8
London 8
Los Angeles 8
Napoli 8
Redwood City 8
Cambridge 7
Seoul 7
Toronto 7
Zanjan 7
Clearwater 6
San Francisco 6
Washington 6
Amsterdam 5
Düsseldorf 5
Kemerovo 5
Redmond 5
Riva 5
San Diego 5
Torino 5
Yicheng 5
Ardabil 4
Berlin 4
Bologna 4
Leawood 4
Patiāla 4
Tokyo 4
Bari 3
Cairo 3
Detroit 3
Forlì 3
Palermo 3
San Mateo 3
Tappahannock 3
Windsor 3
Ypsilanti 3
Zurich 3
Andover 2
Atri 2
Augusta 2
Boston 2
Bratislava 2
Buenos Aires 2
Cachan 2
Cagliari 2
Castelnuovo Rangone 2
Catania 2
Costa Mesa 2
Cutrofiano 2
Dhaka 2
Dong Ket 2
Edinburgh 2
Falkenstein 2
Florence 2
Groningen 2
Totale 7.579
Nome #
Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico. 240
Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario. 162
Gamma Knife radiosurgery in brain metastases from testicular tumors 115
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 115
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 113
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 112
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 105
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer 103
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 103
Current trends in hematopoietic stem cell transplantation in Europe 102
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 102
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 101
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods 99
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 99
Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. 98
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 97
bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer 97
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 96
Terminal transferase expression in relapsed acute myeloid leukaemia 96
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 96
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders 94
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 94
Gram-negative septicemia in patients with hematologic malignancies 93
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 93
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 92
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 91
Cisplatin pharmacokinetics in elderly patients 91
Virtual colonoscopy in the surveillance of suspected HNPCC carriers: a preliminary study 91
Comportamento dell'ACE e del CEA in pazienti affetti da carcinoma polmonare. 90
Pathological,biological and clinical characteristics and surgical mamagement of ederly women with brest cancer 89
A feasibility study for an hospital-based breast cancer registry. 89
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 88
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 87
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 87
Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors 86
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 85
Fanconi's anaemia in adults: study of three families 84
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties 84
Cation content and membrane deformability of heterozygous beta-thalassaemic red blood cells 83
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 83
Analisi di linkage in famiglie con carcinoma mammario ereditario. 83
Use of the ratio of time to progression following first and second line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma 81
Analisi immunoistochimica per la ricerca di micrometastasi osteo midollari nel carcinoma mammario. 81
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis 79
Evoluzione del concetto di dose in chemioterapia: basi teoriche e modelli matematici. Cetto G.L., Molino A. in: “L’intensità di dose in Oncologia Medica”. G.Bonadonna, G.Robustelli della Cuna eds., Edimes, Progressi in Oncologia Clinica 4: pag. 11-22, Pavia 1995 79
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 79
Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.). 78
Ricerca immunoistochimica di micrometastasi osteo midollari in 33 pazienti portatrici di carcinoma della mammella. 78
The antiemetic activity of high dose metoclopramide and high dose alizapride in combination with lorazepam in patients receiving chemotherapy 77
La terapia ad alte dosi nel carcinoma mammario metastatico e nella mastite carcinomatosa. 77
Caratterizzazione di una nuova linea cellulare di melanoma umano. 76
Clinical evaluation of 51 patients with small cell lung cancer (SCLC). 76
Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato. 76
Efficacy of chemotherapy in two cases of extranodal retroperitoneal germ cell tumors. 75
The detection of breast cancer (b.c.) cells in bone marrow (b.m.): comparative analysis of sensitivity and specificity of three different methods. 75
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer 74
Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study 74
[Idiopathic aneurysm of the right ventricle. Report of a case] 73
New standards in the chemotherapy of metastatic hormone-refractory prostate cancer 73
Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis 72
A good death for cancer patients:still a dream? 72
Leucemia linfatica acuta dopo radioterapia e chemioterapia adiuvante (CMF) per cr della mammella. 72
Ifosfamide encephalopathy: a case report 71
Correlazione tra trattamento adiuvante (chemioterapia e/o ormonoterapia), dosaggio RE e RPg, N , comparsa di metastasi in 150 pazienti con carcinoma mammario. 71
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer 69
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia 68
Chemotherapy for metastatic melanoma 68
Economic aspect of high-dose-chemotherapy (HDC): a clinician’s perspective review 68
Anemia, cancro e chemioterapia antiblastica. 68
Gemcitabine (GEM) and Vincristine (VDS) in advanced non-small cell lung cancer(NSCLC) 67
Cytofluorymetric evaluation of DNA ploidy in lung cancer: a broncoscopic study 67
Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination 66
Neo-adjuvant chemotherapy in non-smallcell lung cancer (SSCLC) 66
Comparative analysis of three different methods in detecting breast cells in bone marrow. 65
Replicative fraction in breast carcinoma. An Immunohistochemical study of 236 cases. 65
Multicentric phase II trial of gemcitabine plus epirubucin plus paclitaxel as first-line chemotherapy in metastatic breast cancer. 64
Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.). 64
Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi. 64
Prognostic significance of estrogen and progesterone receptors (RE and PR) in 234 breast cancer patients. 64
Comportamento del CA 15 3 nelle pazienti affette da carcinoma mammario (stadio I III). 63
Impact of a breast cancer registry on the management of breast cancer patients 62
A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results. 62
Phase I°/II° trial of recombinant alfha 2 interferon (IFN) and Vinblastine (VBL) in metastatic renal cell cancer (MRCC). 62
Comparative analysis of three different techniques in detecting breast cancer (b.c.) cells in bone marrow (b.m.). 62
The Gemcitabine/Epirubicin /Paclitaxel trials in advanced breast cancer 61
Anemia, cancro e chemioterapia antiblastica. 61
Attività proliferativa del carcinoma mammario: studio su 329 pazienti. 61
Inductively coupled plasma mass spectroscopy (ICP-MS) quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin or carboplatin based chemotherapy 60
Bone metastases from primary cardiac sarcoma: case report 60
Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone 60
Caratterizzazione fenotipica di cloni ottenuti da una linea cellulare di melanoma umano. 59
Adjuvant chemotherapy with high-dose epirubicin and cyclophosphamide vs CMF in high-risk premenopausal breast cancer patients (pts). Prospective randomized phase III trial. 59
Immunodetection of breast cancer cells in bone marrow for monitoring high-dose sequential chemotherapy 58
Prognostic significance of laminin, laminin receptor and bone marrow micrometastases in breast cancer patinets. Are these markers of aggressive behavior and metastatic potential? 58
Analisi puntiforme dei valori sierici del CA 15.3 e del CEA in pazienti con carcinoma della mammella. 58
Dosaggio della NSE in pazienti affetti da tumori di origine neuroectodermica. 58
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 58
Attività di un Registro Tumori di Patologia Mammaria su base ospedaliera. 58
Correlations between family history and cancer characteristics in 2256 breast cancer patients. 57
Modulation of antigen expression in a new human melanoma cell line with a high growth potential and stable properties. 57
Totale 8.094
Categoria #
all - tutte 31.659
article - articoli 13.945
book - libri 1.370
conference - conferenze 16.344
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019124 0 0 0 0 0 0 0 0 0 20 34 70
2019/20201.588 215 24 12 177 94 238 125 190 86 196 57 174
2020/20211.403 72 233 86 110 148 208 16 177 140 11 165 37
2021/20221.482 77 463 13 207 78 37 33 77 64 31 128 274
2022/20232.556 206 219 272 365 345 632 23 141 271 18 45 19
2023/2024776 40 114 90 113 146 152 39 39 5 38 0 0
Totale 10.858